|
FANCL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51804999999339E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.595600E-04 |
| Normal-vs-Stage2 |
1.367590E-02 |
| Normal-vs-Stage3 |
4.160100E-03 |
| Normal-vs-Stage4 |
4.950500E-02 |
| Stage1-vs-Stage2 |
7.462800E-01 |
| Stage1-vs-Stage3 |
3.415400E-01 |
| Stage1-vs-Stage4 |
5.470600E-01 |
| Stage2-vs-Stage3 |
6.674800E-01 |
| Stage2-vs-Stage4 |
7.340600E-01 |
| Stage3-vs-Stage4 |
9.816000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76222999999087E-05 |
| Normal-vs-AfricanAmerican |
5.821500E-03 |
| Normal-vs-Asian |
5.867900E-02 |
| Caucasian-vs-AfricanAmerican |
3.776600E-01 |
| Caucasian-vs-Asian |
1.469830E-01 |
| AfricanAmerican-vs-Asian |
1.217180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.440530E-04 |
| Normal-vs-Female |
1.17639999996921E-06 |
| Male-vs-Female |
2.372300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.898900E-03 |
| Normal-vs-Extreme_Weight |
5.841400E-04 |
| Normal-vs-Obese |
2.574200E-04 |
| Normal-vs-Extreme_Obese |
2.401600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.203800E-01 |
| Normal_Weight-vs-Obese |
8.336400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.864800E-01 |
| Extreme_Weight-vs-Obese |
4.919000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.544600E-01 |
| Obese-vs-Extreme_Obese |
2.388800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.119300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.54865999999476E-05 |
| Normal-vs-Age(61-80Yrs) |
3.223400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.743400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.301800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.010330E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.313590E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.199600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.646000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.110400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.23609999999908E-06 |
| Normal-VS-Type2 PRCC |
1.418220E-01 |
| Normal-VS-KIRP CIMP |
1.736530E-03 |
| Normal-VS-Unclassified PRCC |
3.823500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.341500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.358900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.605200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.039730E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.303700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.021880E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.376600E-03 |
| Normal-vs-N1 |
7.183100E-04 |
| Normal-vs-N2 |
2.792300E-02 |
| N0-vs-N1 |
3.530300E-02 |
| N0-vs-N2 |
5.929200E-01 |
| N1-vs-N2 |
5.537800E-01 |
|
|
